Insight Inv LLC Acquires 20,001 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Insight Inv LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6,601.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,304 shares of the healthcare conglomerate's stock after buying an additional 20,001 shares during the period. UnitedHealth Group makes up 4.0% of Insight Inv LLC's portfolio, making the stock its 5th biggest position. Insight Inv LLC's holdings in UnitedHealth Group were worth $10,634,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nabity Jensen Investment Management Inc boosted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock valued at $1,446,000 after purchasing an additional 24 shares during the period. Valley National Advisers Inc. increased its holdings in UnitedHealth Group by 7.8% during the 1st quarter. Valley National Advisers Inc. now owns 1,215 shares of the healthcare conglomerate's stock worth $635,000 after purchasing an additional 88 shares during the last quarter. Custos Family Office LLC boosted its stake in shares of UnitedHealth Group by 50.8% during the 1st quarter. Custos Family Office LLC now owns 983 shares of the healthcare conglomerate's stock valued at $515,000 after buying an additional 331 shares during the last quarter. Northwest Wealth Management LLC increased its position in shares of UnitedHealth Group by 18.4% in the 1st quarter. Northwest Wealth Management LLC now owns 700 shares of the healthcare conglomerate's stock worth $367,000 after purchasing an additional 109 shares during the last quarter. Finally, Amalgamated Bank grew its position in shares of UnitedHealth Group by 0.8% in the 1st quarter. Amalgamated Bank now owns 186,742 shares of the healthcare conglomerate's stock worth $97,806,000 after acquiring an additional 1,446 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $308.85 on Monday. The company's 50 day moving average price is $336.21 and its two-hundred day moving average price is $453.53. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $280.17 billion, a PE ratio of 12.93, a PEG ratio of 1.46 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the business posted $6.91 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director John H. Noseworthy acquired 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company's stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by company insiders.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Barclays dropped their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. HSBC restated a "reduce" rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Oppenheimer reduced their price objective on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. TD Securities reissued a "hold" rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.